Societe Generale Effekten News - S31922

Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing

NEWPORT, Ky., June 4 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc. is pleased to announce that Michael J. Valentino has been named to the...

Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.

CHESTER, N.J. and SLOUGH, England, Jan. 30 /PRNewswire/ -- Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") today announced the...

Adams Respiratory Therapeutics, Inc.-removal from listing & reg. of matured, redeemed/retired sec. Initial Filing Ame.. (25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...

QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Inde

NEW YORK, Jan. 29 /PRNewswire/ -- QED International Associates, Inc, administrator for the HealthShares(TM) Indexes, a series of 20 underlying...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Societe Generale Effekten (S31922)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

S31922 News

Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing

Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.

Adams Respiratory Therapeutics, Inc.-removal from listing & reg. of matured, redeemed/retired sec. Initial Filing Ame.. (25-NSE)

QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Inde

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

S31922 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Societe Generale Effekten (S31922) News

Societe Generale Effekten (S31922)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

S31922 News

Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing

Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.

Adams Respiratory Therapeutics, Inc.-removal from listing & reg. of matured, redeemed/retired sec. Initial Filing Ame.. (25-NSE)

QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Inde

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

Adams Respiratory Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)

S31922 Discussion

Your Recent History